Home NDC 52599-282 Baclezene
Product NDC 52599-282
11-digit product format 525990282
Labeler code 52599
Product ID 52599-282_5f3b6e5c-8332-2f0d-e053-2a91aa0a7d0f
Type HUMAN OTC DRUG
Nonproprietary name Neomycin Sulfate
Dosage form CREAM
Route TOPICAL
Labeler Curazene, LLC
Application part333B
Marketing category OTC MONOGRAPH FINAL
Marketing start 2014-06-19
Marketing end 0000-00-00
Substance NEOMYCIN SULFATE
Active strength 5 mg/.9g
NDC exclude flag E
Listing certified through 2018-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 38 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Code Status Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 52599-282-83 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 52599-282-83 D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 52599-282-83 D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 52599-282-83 D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 52599-282-83 D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 52599-282-83 D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product D Discontinued by firm 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 52599-282-83 D Discontinued by firm 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product D Discontinued by firm ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 52599-282-83 D Discontinued by firm ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product D Discontinued by firm 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 52599-282-83 D Discontinued by firm 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product D Discontinued by firm ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 52599-282-83 D Discontinued by firm ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product D Discontinued by firm 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 52599-282-83 D Discontinued by firm 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product D Discontinued by firm 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 52599-282-83 D Discontinued by firm 557ba5c1ecfa…9c80585c8c6e…2022-08-30 03:57 UTC · source 2022-08-29 excluded product product I Inactivated by FDA fb8cb913e6d1…eb8c232b6be0…2022-08-30 03:57 UTC · source 2022-08-29 excluded package package 52599-282-83 I Inactivated by FDA fb8cb913e6d1…eb8c232b6be0…2022-04-09 23:13 UTC · source 2022-04-08 excluded product product I Inactivated by FDA 86f5da6cb304…a595104c45d7…2022-04-09 23:13 UTC · source 2022-04-08 excluded package package 52599-282-83 I Inactivated by FDA 86f5da6cb304…a595104c45d7…2022-04-04 05:40 UTC · source 2022-04-01 excluded product product I Inactivated by FDA bd6a592717d7…303034d00443…2022-04-04 05:40 UTC · source 2022-04-01 excluded package package 52599-282-83 I Inactivated by FDA bd6a592717d7…303034d00443…2021-12-27 23:28 UTC · source 2021-12-27 excluded product product I Inactivated by FDA 8dfbde2a14a4…c9ff85d89658…2021-12-27 23:28 UTC · source 2021-12-27 excluded package package 52599-282-83 I Inactivated by FDA 8dfbde2a14a4…c9ff85d89658…2020-12-18 03:04 UTC · source 2020-12-17 excluded product product I Inactivated by FDA e2bbac7714bc…27bdfed8d636…2020-12-18 03:04 UTC · source 2020-12-17 excluded package package 52599-282-83 I Inactivated by FDA e2bbac7714bc…27bdfed8d636…2020-06-10 20:45 UTC · source 2020-06-10 excluded product product I Inactivated by FDA 9bebd1f3094a…5416666fcb17…2020-06-10 20:45 UTC · source 2020-06-10 excluded package package 52599-282-83 I Inactivated by FDA 9bebd1f3094a…5416666fcb17…2019-12-08 06:16 UTC · source 2019-12-05 excluded product product E Excluded after deficient or non-compliant submission was not corrected 110d247fa046…a55b01930146…2019-12-08 06:16 UTC · source 2019-12-05 excluded package package 52599-282-83 E Excluded after deficient or non-compliant submission was not corrected 110d247fa046…a55b01930146…
FDA-Initiated Inactive NDC Indexing# DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded NEOMYCIN SULFATE ACTIVE INGREDIENT 057Y626693 BACLEZENE (NEOMYCIN SULFATE) CREAM [CURAZENE, LLC] 3 NEOMYCIN ACTIVE MOIETY I16QD7X297 BACLEZENE (NEOMYCIN SULFATE) CREAM [CURAZENE, LLC] 3 ASCORBIC ACID INACTIVE INGREDIENT PQ6CK8PD0R BACLEZENE (NEOMYCIN SULFATE) CREAM [CURAZENE, LLC] 3 BENZOIC ACID INACTIVE INGREDIENT 8SKN0B0MIM BACLEZENE (NEOMYCIN SULFATE) CREAM [CURAZENE, LLC] 3 CHLORPHENESIN INACTIVE INGREDIENT I670DAL4SZ BACLEZENE (NEOMYCIN SULFATE) CREAM [CURAZENE, LLC] 3 CITRIC ACID MONOHYDRATE INACTIVE INGREDIENT 2968PHW8QP BACLEZENE (NEOMYCIN SULFATE) CREAM [CURAZENE, LLC] 3 GLYCERIN INACTIVE INGREDIENT PDC6A3C0OX BACLEZENE (NEOMYCIN SULFATE) CREAM [CURAZENE, LLC] 3 GLYCERYL MONOSTEARATE INACTIVE INGREDIENT 230OU9XXE4 BACLEZENE (NEOMYCIN SULFATE) CREAM [CURAZENE, LLC] 3 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 BACLEZENE (NEOMYCIN SULFATE) CREAM [CURAZENE, LLC] 3 METHYLPARABEN INACTIVE INGREDIENT A2I8C7HI9T BACLEZENE (NEOMYCIN SULFATE) CREAM [CURAZENE, LLC] 3 PETROLATUM INACTIVE INGREDIENT 4T6H12BN9U BACLEZENE (NEOMYCIN SULFATE) CREAM [CURAZENE, LLC] 3 PHENOXYETHANOL INACTIVE INGREDIENT HIE492ZZ3T BACLEZENE (NEOMYCIN SULFATE) CREAM [CURAZENE, LLC] 3 POLYSORBATE 80 INACTIVE INGREDIENT 6OZP39ZG8H BACLEZENE (NEOMYCIN SULFATE) CREAM [CURAZENE, LLC] 3 SODIUM CITRATE INACTIVE INGREDIENT 1Q73Q2JULR BACLEZENE (NEOMYCIN SULFATE) CREAM [CURAZENE, LLC] 3 STEARIC ACID INACTIVE INGREDIENT 4ELV7Z65AP BACLEZENE (NEOMYCIN SULFATE) CREAM [CURAZENE, LLC] 3